Development of a high-throughput Candida albicans biofilm chip.

We have developed a high-density microarray platform consisting of nano-biofilms of Candida albicans. A robotic microarrayer was used to print yeast cells of C. albicans encapsulated in a collagen matrix at a volume as low as 50 nL onto surface-modified microscope slides. Upon incubation, the cells...

Full description

Bibliographic Details
Main Authors: Anand Srinivasan, Priya Uppuluri, Jose Lopez-Ribot, Anand K Ramasubramanian
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-04-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3081316?pdf=render
_version_ 1811205492500856832
author Anand Srinivasan
Priya Uppuluri
Jose Lopez-Ribot
Anand K Ramasubramanian
author_facet Anand Srinivasan
Priya Uppuluri
Jose Lopez-Ribot
Anand K Ramasubramanian
author_sort Anand Srinivasan
collection DOAJ
description We have developed a high-density microarray platform consisting of nano-biofilms of Candida albicans. A robotic microarrayer was used to print yeast cells of C. albicans encapsulated in a collagen matrix at a volume as low as 50 nL onto surface-modified microscope slides. Upon incubation, the cells grow into fully formed "nano-biofilms". The morphological and architectural complexity of these biofilms were evaluated by scanning electron and confocal scanning laser microscopy. The extent of biofilm formation was determined using a microarray scanner from changes in fluorescence intensities due to FUN 1 metabolic processing. This staining technique was also adapted for antifungal susceptibility testing, which demonstrated that, similar to regular biofilms, cells within the on-chip biofilms displayed elevated levels of resistance against antifungal agents (fluconazole and amphotericin B). Thus, results from structural analyses and antifungal susceptibility testing indicated that despite miniaturization, these biofilms display the typical phenotypic properties associated with the biofilm mode of growth. In its final format, the C. albicans biofilm chip (CaBChip) is composed of 768 equivalent and spatially distinct nano-biofilms on a single slide; multiple chips can be printed and processed simultaneously. Compared to current methods for the formation of microbial biofilms, namely the 96-well microtiter plate model, this fungal biofilm chip has advantages in terms of miniaturization and automation, which combine to cut reagent use and analysis time, minimize labor intensive steps, and dramatically reduce assay costs. Such a chip should accelerate the antifungal drug discovery process by enabling rapid, convenient and inexpensive screening of hundreds-to-thousands of compounds simultaneously.
first_indexed 2024-04-12T03:33:37Z
format Article
id doaj.art-b8be15fa3a444d0bbcb78f92728f9f0d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T03:33:37Z
publishDate 2011-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b8be15fa3a444d0bbcb78f92728f9f0d2022-12-22T03:49:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-04-0164e1903610.1371/journal.pone.0019036Development of a high-throughput Candida albicans biofilm chip.Anand SrinivasanPriya UppuluriJose Lopez-RibotAnand K RamasubramanianWe have developed a high-density microarray platform consisting of nano-biofilms of Candida albicans. A robotic microarrayer was used to print yeast cells of C. albicans encapsulated in a collagen matrix at a volume as low as 50 nL onto surface-modified microscope slides. Upon incubation, the cells grow into fully formed "nano-biofilms". The morphological and architectural complexity of these biofilms were evaluated by scanning electron and confocal scanning laser microscopy. The extent of biofilm formation was determined using a microarray scanner from changes in fluorescence intensities due to FUN 1 metabolic processing. This staining technique was also adapted for antifungal susceptibility testing, which demonstrated that, similar to regular biofilms, cells within the on-chip biofilms displayed elevated levels of resistance against antifungal agents (fluconazole and amphotericin B). Thus, results from structural analyses and antifungal susceptibility testing indicated that despite miniaturization, these biofilms display the typical phenotypic properties associated with the biofilm mode of growth. In its final format, the C. albicans biofilm chip (CaBChip) is composed of 768 equivalent and spatially distinct nano-biofilms on a single slide; multiple chips can be printed and processed simultaneously. Compared to current methods for the formation of microbial biofilms, namely the 96-well microtiter plate model, this fungal biofilm chip has advantages in terms of miniaturization and automation, which combine to cut reagent use and analysis time, minimize labor intensive steps, and dramatically reduce assay costs. Such a chip should accelerate the antifungal drug discovery process by enabling rapid, convenient and inexpensive screening of hundreds-to-thousands of compounds simultaneously.http://europepmc.org/articles/PMC3081316?pdf=render
spellingShingle Anand Srinivasan
Priya Uppuluri
Jose Lopez-Ribot
Anand K Ramasubramanian
Development of a high-throughput Candida albicans biofilm chip.
PLoS ONE
title Development of a high-throughput Candida albicans biofilm chip.
title_full Development of a high-throughput Candida albicans biofilm chip.
title_fullStr Development of a high-throughput Candida albicans biofilm chip.
title_full_unstemmed Development of a high-throughput Candida albicans biofilm chip.
title_short Development of a high-throughput Candida albicans biofilm chip.
title_sort development of a high throughput candida albicans biofilm chip
url http://europepmc.org/articles/PMC3081316?pdf=render
work_keys_str_mv AT anandsrinivasan developmentofahighthroughputcandidaalbicansbiofilmchip
AT priyauppuluri developmentofahighthroughputcandidaalbicansbiofilmchip
AT joselopezribot developmentofahighthroughputcandidaalbicansbiofilmchip
AT anandkramasubramanian developmentofahighthroughputcandidaalbicansbiofilmchip